Uterine Sarcomas: The Curie Institut Experience. Prognosis Factors and Adjuvant Treatments
- 1 February 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 72 (2) , 232-237
- https://doi.org/10.1006/gyno.1998.5251
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Prognostic Significance of Surgery, Tumor Size, Malignancy Grade, Menopausal Status, and DNA Ploidy in Endometrial Stromal SarcomaGynecologic Oncology, 1996
- Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.Journal of Clinical Oncology, 1996
- Flow Cytometric Analysis of Uterine SarcomasGynecologic Oncology, 1994
- A Multivariate Analysis of Clinicopathologic Factors for Predicting Outcome in Uterine SarcomasGynecologic Oncology, 1994
- Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patientsThe British Journal of Radiology, 1993
- Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of RecurrenceGynecologic Oncology, 1993
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcomaBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Retrospective analysis of 318 cases of uterine sarcomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Radiotherapy in the treatment of sarcomas of the corpus uteriCancer, 1969